VQUIN

Preventing multi-drug resistant tuberculosis in a high prevalence setting: ‘Connecting the DOTS’ in Vietnam

STUDY SITES: Hanoi, Nam Dinh, Thanh Hoa, Khanh Hoa, Da Nang, Quang Nam, Ho Chi Minh City, Tien Giang, An Giang and Can Tho

TIMELINE: 2016 – 2020

PROJECT IMPLEMENTER: National Lung Hospital / National TB Program

FUNDED BY: National Health and Medical Research Council (NHMRC)

CORE STAKEHOLDERS: Provincial Lung Hospitals of 10 project provinces

PRINCIPAL INVESTIGATOR: Professor Greg Fox, The University of Sydney and the Woolcock Institute of Medical Research

VIETNAMESE PRINCIPAL INVESTIGATOR: Associate Professor Nguyen Viet Nhung, National Lung Hospital

PRIMARY OBJECTIVE: To test the effectiveness of levofloxacin given for 6 months, compared to placebo, in the prevention of active TB among household contacts of patients with MDR-TB who have latent tuberculosis infection.

This study was registered as a clinical trial under number: ACTRN12616000215426

Publications

tuberculosis-study-vietnam